Metomni R XL 25/2.5

Metomni R XL 25/2.5 by EMK Omni Pharma is a prescription-based Metoprolol Succinate SR and Ramipril Tablets formulation used for doctor-supervised blood pressure management, heart rate control, and cardiovascular health support. Each film-coated tablet contains Metoprolol Succinate IP 23.75 mg (equivalent to Metoprolol Tartrate 25 mg) in sustained release form and Ramipril IP 2.5 mg. Metomni R XL 25/2.5 is commonly prescribed by healthcare professionals for patients who require support in managing hypertension, high blood pressure, cardiac workload, heart rate regulation, and long-term cardiovascular risk management. The sustained release Metoprolol component supports controlled cardiac care, while Ramipril supports physician-guided blood pressure and heart health management.

Metomni R XL 25/2.5 may be prescribed by doctors for patients who require support in managing high blood pressure, hypertension, elevated heart rate, cardiac strain, and cardiovascular risk factors. It may be used as part of a physician-guided heart care plan for individuals who need blood pressure control, heart rate management, and long-term cardiac health support. Metomni R XL 25/2.5 by EMK Omni Pharma is suitable for doctor-supervised treatment where blood pressure management, cardiac workload reduction, heart rate regulation, and cardiovascular support are required. Patients should not self-medicate, change the dosage, stop the medicine suddenly, chew or crush the tablet, or combine it with other medicines without consulting their doctor.